Role of Helicobacter pylori in patients with HCV-related chronic hepatitis and cirrhosis with or without hepatocellular carcinoma: Possible association with disease progression

Journal of Viral Hepatitis

Volumn 19, Issue 7, 2012, Pages 473-479

  Esmat, G ^a   El Bendary, Mahmoud ^b   Zakarya, S ^b   Ela, M A ^b   Zalata, K ^b  

^a CAIRO UNIVERSITY   (Egypt)

^b MANSOURA UNIVERSITY   (Egypt)

Author keywords

Cag A gene; Chronic hepatitis; Cirrhosis; H. Pylori; Hepatitis C virus; Hepatocellular carcinoma; Metavir

Indexed keywords

VIRUS RNA;

ADULT; ARTICLE; BIOCHEMISTRY; CANCER STAGING; CHRONIC HEPATITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HELICOBACTER PYLORI; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RADIOLOGY; REAL TIME POLYMERASE CHAIN REACTION;

ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BIOPSY; DISEASE PROGRESSION; DNA, BACTERIAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; POLYMERASE CHAIN REACTION; RNA, VIRAL; SEVERITY OF ILLNESS INDEX;

EID: 84862176258     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2011.01567.x     Document Type: Article

References (37)

1. Lehman E, Wilson M. Epidemiology of hepatitis viruses among hepatocellular carcinoma cases and healthy people in Egypt: a systematic review and meta analysis. Int J Cancer 2009; 124(3): 690-697.
2. Parkin D. The global health burden of infection associated cancers in the year 2002. Int J Cancer 2006; 118(12): 3030-3044.
3. International Agency for research on Cancer. Evaluation of carcinogenic risks to humans. Schistosomes I. liver flukes and Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum 1994; 61: 177-240.
4. Solnick J, Schauer D. Emergence of diverse Helicobacter species in the pathogenesis of gastric and enterohepatic diseases. Clin Microbiol Rev 2001; 14(1): 59.
5. Rocha M, Avenaud P, Menard A et al. Association of Helicobacter species with hepatitis C cirrhosis with or without hepatocellular carcinoma. BMJ 2005; 54(3):396.
6. El-Masry S, El-Shahat M, Badra G, Aboel-Nour M, Lotfy M. Helicobacter pylori and hepatitis C virus coinfection in Egyptian patients. J Glob Infect Dis 2010; 2(1): 4.
7. Pellicano R, Leone N, Berrutti M et al. Helicobacter pylori seroprevalence in hepatitis C virus positive patients with cirrhosis. J Hepatol 2000; 33(4): 648-650.
8. Leone N, Pellicano R, Brunello F et al. Helicobacter pylori seroprevalence in patients with cirrhosis of the liver and hepatocellular carcinoma. Cancer Detect Prev 2003; 27(6): 494-497. (Pubitemid 37506964)
9. Fagoonee S, Pellicano R, Rizzetto M, Ponzetto A. The journey from hepatitis to hepatocellular carcinoma. Bridging role of Helicobacter species. Panminerva Med 2001; 43(4): 279.
10. Ponzetto A, Pellicano R, Leone N et al. Helicobacter infection and cirrhosis in hepatitis C virus carriage: is it an innocent bystander or a troublemaker?. Med Hypotheses 2000; 54(2): 275-277. (Pubitemid 30170974)
11. O'Rourke J, Solnick J, Neilan B et al. Description of 'Candidatus Helicobacter heilmannii' based on DNA sequence analysis of 16S rRNA and urease genes. Int J Syst Evol Microbiol 2004; 54(6): 2203.
12. Argent R, Kidd M, Owen R, Thomas R, Limb M, Atherton J. Determinants and consequences of different levels of CagA phosphorylation for clinical isolates of Helicobacter pylori. Gastroenterology 2004; 127(2): 514-523. (Pubitemid 39091900)
13. Argent R, Zhang Y, Atherton J. Simple method for determination of the number of Helicobacter pylori CagA variable-region EPIYA tyrosine phosphorylation motifs by PCR. J Clin Microbiol 2005; 43(2): 791.
14. Abou El ela M, Omar N, ElBendary M, El-Naggar M, Zalata K, Ibrahim T. Association between Helicobacter pylori and hepatitis C virus-related chronic liver diseases: serological and molecular study. Egypt J Med Microbiol 2005; 14(1): 1-12.
15. Bedossa P, Poynard T. The METAVIR cooperative study group. An algorithm for the grading of activity in chronic hepatitis C. Hepatology 1996; 24(2): 289-293. (Pubitemid 26260021)
16. Avenaud P, Marais A, Monteiro L et al. Detection of Helicobacter species in the liver of patients with and without primary liver carcinoma. Cancer 2000; 89(7): 1431-1439.
17. Dore M, Mura D, Deledda S, Maragkoudakis E, Pironti A, Realdi G. Active peptic ulcer disease in patients with hepatitis C virus-related cirrhosis: the role of Helicobacter pylori infection and portal hypertensive gastropathy. Can J Gastroenterol 2004; 18(8): 521.
18. Covacci A, Censini S, Bugnoli M et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 1993; 90(12): 5791.
19. Huang Y, Fan X, Wang Z, Zhou J, Tian X, Li N. Identification of Helicobacter species in human liver samples from patients with primary hepatocellular carcinoma. J Clin Pathol 2004; 57(12): 1273.
20. World Medical Association (WMA). Declaration of Helsinki; ethical principles for medical research involving human subjects. 59th WMA General Assembly Seoul, October 2008.
21. Zullo A, Hassan C, Morini S. Helicobacter pylori infection in patients with liver cirrhosis: facts and fictions. Dig Liver Dis 2003; 35(3): 197-205. (Pubitemid 40668465)
22. Vergara M, Calvet X, Roqué M. Helicobacter pylori is a risk factor for peptic ulcer disease in cirrhotic patients. A meta-analysis. Eur J Gastroenterol Hepatol 2002; 14(7): 717.
23. Tiwari S, Khan A, Ibrahim M, Habeeb M, Habibullah C. Helicobacter pylori and other Helicobacter species DNA in human bile samples from patients with various hepato-biliary diseases. World J Gastroenterol 2006; 12(14): 2181.
24. Pellicano R, Ménard A, Rizzetto M, Mégraud F. Helicobacter species and liver diseases: association or causation? The Lancet Infect Dis 2008; 8(4): 254-260. (Pubitemid 351382026)
25. Tsai C. Helicobacter pylori infection and peptic ulcer disease in cirrhosis. Dig Dis Sci 1998; 43(6): 1219-1225. (Pubitemid 28272555)
26. Pellicano R, Mazzaferro V, Grigioni W et al. Helicobacter species sequences in liver samples from patients with and without hepatocellular carcinoma. World J Gastroenterol 2004; 10(4): 598-601. (Pubitemid 38325323)
27. Ceelen L, Decostere A, Verschraegen G, Ducatelle R, Haesebrouck F. Prevalence of Helicobacter pullorum among patients with gastrointestinal disease and clinically healthy persons. J Clin Microbiol 2005; 43(6): 2984.
28. Avenaud P, Castroviejo M, Claret S, Rosenbaum J, Mégraud F, Ménard A. Expression and activity of the cytolethal distending toxin of Helicobacter hepaticus. Biochem Biophys Res Commun 2004; 318(3): 739-745. (Pubitemid 38624217)
29. Taylor N, Ge Z, Shen Z, Dewhirst F, Fox J. Cytolethal distending toxin: a potential virulence factor for Helicobacter cinaedi. J Infect Dis 2003; 188(12): 1892-1897. (Pubitemid 38064876)
30. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001; 357(9255): 539-545. (Pubitemid 32173595)
31. Abdel-Hady H, Zaki A, Badra G et al. Helicobacter pylori infection in hepatic encephalopathy: relationship to plasma endotoxins and blood ammonia. Hepatol Res 2007; 37(12): 1026-1033. (Pubitemid 350028329)
32. El-Omar E, Carrington M, Chow W et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404(6776): 398-402. (Pubitemid 30164342)
33. Goo M, Ki M, Lee H et al. Helicobacter pylori promotes hepatic fibrosis in the animal model. Lab Invest 2009; 89(11): 1291-1303.
34. Ki M, Goo M, Park J et al. Helicobacter pylori accelerates hepatic fibrosis by sensitizing transforming growth factor- 1-induced inflammatory signaling. Lab Invest 2010; 90(10): 1507-1516.
35. Wheeler M, Kono H, Yin M, Nakagami M, Uesugi T, Arteel G. The role of Kupffer cell oxidant production in early ethanol-induced liver disease. Free Radic Biol Med 2001; 31(12): 1544.
36. Garcia Trevijano E, Iraburu M, Fontana L et al. Transforming growth factor 1 induces the expression of alpha1(I) procollagen mRNA by a hydrogen peroxide C/EBP dependent mechanism in rat hepatic stellate cells. Hepatology 1999; 29(3): 960-970. (Pubitemid 29109616)
37. Berasain C, Perugorria M, Ujue Latasa M et al. The epidermal growth factor receptor: a link between inflammation and liver cancer. Exp Biol Med 2009; 234(7): 713-725.